No Detail Found!

Frequency and E ect of Cutaneous Manifestations on Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis

Author(s)
Ahsan Tameezuddin Department of Internal Medicine, Islamabad Medical Complex,Islamabad,Pakistan
Ifrah Javed Malik Department of Psychiatry, Institute of Psychiatry & WHO Collaborating Centre for Research, Benazir Bhutto Hospital,Rawalpindi,Pakistan
Daneyal Arshad Department of Internal Medicine, Rawalpindi Medical University,Rawalpindi,Pakistan
Asim Tameezuddin Department of Internal Medicine, Islamabad Medical Complex,Islamabad,Pakistan
Noman Ahmed Chaudhary Department of Internal Medicine, Capital Hospital,Islamabad,Pakistan
Zulqarnain Asad Department of Internal Medicine, Rawalpindi Medical University,Rawalpindi,Pakistan
Abstract
Objective: To determine the frequency of skin manifestations found in end-stage renal disease (ESRD) patients undergoing dialysis, while assessing their e ect on the quality of lives of the same patients. Study Design: Descriptive cross-sectional study. Place and Duration of the Study: Benazir Bhutto Hospital, Holy Family Hospital, and Hussain Lakhani Hospital, from 12th December 2021 to 13th October 2022. Methodology: Seventy-three Patients undergoing hemodialysis were enrolled in the study. Skin manifestations were de ned as cutaneous signs and symptoms related to ESRD unrelated to the symptoms resulting from any primary dermatological disorder or other systemic diseases . Data on the skin manifestations of their disease and their e ect on patients quality of life were collected by using a 2-part questionnaire. The rst part consisted of demographic details along with the type of skin disorders faced by the patient and the second part of the questionnaire comprised of the dermatology life quality index (DLQI). The data were entered and analysed using the statistical package for social sciences (SPSS) version 23.0. Results: Xerosis and pruritus were most commonly reported (83.7%), followed by nail changes (18.6%) and skin discolouration (16.3%). The median duration of dialysis was 36 (1-180) months and there was no signi cant increase in skin symptoms with the increase in the duration of dialysis (p=0.082). The median DLQI score was 3 (range:0-10) A signi cantly higher number of females (n=14) reported associated mental discomfort with their skin symptoms of pruritis as compared to males (n=5, p=0.008). Conclusion: Cutaneous manifestations have variable e ects on the quality of life of ESRD patients. Adopting a multidisciplinary approach early in the management may help to minimise the mental discomfort of these patients and bring an improvement in their quality of life.
Publication Details
Page(s) 406-410
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 4, Year: 2023

Request the full text from PASTIC

Keywords
Hemodialysis, Quality of life, pruritus, skin manifestations, End-stage renal disease (ESRD)
0

Citations

0

Downloads

113

Views